Antibacterial agents in clinical development
an analysis of the antibacterial clinical development pipeline, including tuberculosis
7 September 2017
| Technical document
WHO Team
Antimicrobial Resistance Division (AMR),
Surveillance, Prevention and Control (SPC)
Number of pages
45
Reference numbers
WHO Reference Number: WHO/EMP/IAU/2017.11
Copyright
